GLUT1 gene is a potential hypoxic marker in colorectal cancer patients

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Chung, Fu Yen ^a   Huang, Ming Yii ^a,b,c   Yeh, Ching Sheng ^d,e   Chang, Hui Jen ^d,e   Cheng, Tian Lu ^a   Yen, Li Chen ^a   Wang, Jaw Yuan ^b,c   Lin, Shiu Ru ^d,e  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d FOOYIN UNIVERSITY   (Taiwan)

^e FOOYIN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; LACTIC ACID; MESSENGER RNA; ARNT PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1BETA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CELL CULTURE; CANCER PATIENT; COLON ADENOCARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANOXIA; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TIME; TUMOR CELL LINE;

ADULT; AGED; ANOXIA; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MIDDLE AGED; RNA, MESSENGER; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 69349105825     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-241     Document Type: Article

References (51)

1. Coleman CN Modulating the radiation response Stem Cells 1996, 14(1):10-15. 8820945
2. Tredan O Galmarini CM Patel K Tannock IF Drug resistance and the solid tumor microenvironment J Natl Cancer Inst 2007, 99(19):1441-1454. 17895480
3. Brizel DM Scully SP Harrelson JM Layfield LJ Bean JM Prosnitz LR Dewhirst MW Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma Cancer Res 1996, 56(5):941-943. 8640781
4. Tatum JL Kelloff GJ Gillies RJ Arbeit JM Brown JM Chao KS Chapman JD Eckelman WC Fyles AW Giaccia AJ et al Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy Int J Radiat Biol 2006, 82(10):699-757. 17118889
5. Birner P Schindl M Obermair A Plank C Breitenecker G Oberhuber G Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer Cancer Res 2000, 60(17):4693-4696. 10987269
6. Le QT Kong C Lavori PW O'Byrne K Erler JT Huang X Chen Y Cao H Tibshirani R Denko N et al Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 2007, 69(1):167-175. 17707270
7. Movsas B Chapman JD Hanlon AL Horwitz EM Greenberg RE Stobbe C Hanks GE Pollack A Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: Preliminary findings Urology 2002, 60(4):634-639. 12385924
8. Yoshimura H Dhar DK Kohno H Kubota H Fujii T Ueda S Kinugasa S Tachibana M Nagasue N Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: Correlation with tumor angiogenesis and cyclooxygenase-2 expression Clin Cancer Res 2004, 10(24):8554-8560. 15623639
9. Hockel M Knoop C Schlenger K Vorndran B Baussmann E Mitze M Knapstein PG Vaupel P Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix Radiother Oncol 1993, 26(1):45-50. 8438086
10. Vaupel P Hockel M Mayer A Detection and characterization of tumor hypoxia using pO2 histography Antioxid Redox Signal 2007, 9(8):1221-1235. 17536958
11. Auer F Roper B Scheich D Molls M Eiermann W Raab G Technical improvement of pO(2) measurements in breast cancer: Investigation of the feasibility in patients and in vitro validation of the method Strahlenther Onkol 2007, 183(5):265-270. 17497098
12. Jankovic B Aquino-Parsons C Raleigh JA Stanbridge EJ Durand RE Banath JP MacPhail SH Olive PL Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix Cytometry B Clin Cytom 2006, 70(2):45-55. 16456867
13. Terpstra M High WB Luo Y de Graaf RA Merkle H Garwood M Relationships among lactate concentration, blood flow and histopathologic profiles in rat C6 glioma NMR Biomed 1996, 9(5):185-194. 9067999
14. Quintero M Mackenzie N Brennan PA Hypoxia-inducible factor 1 (HIF-1) in cancer Eur J Surg Oncol 2004, 30(5):465-468. 15135470
15. Herszenyi L Farinati F Cardin R Istvan G Molnar LD Hritz I De Paoli M Plebani M Tulassay Z Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer BMC Cancer 2008, 8:194. 2474636 18616803
16. Li M Li JY Zhao AL He JS Zhou LX Li YA Gu J Comparison of Carcinoembryonic Antigen (CEA) Prognostic Value in Serum and Tumor Tissue of Patients with Colorectal Cancer Colorectal Dis 2009, 11(3):276-281. 18513194
17. de Geus-Oei LF van Laarhoven HW Visser EP Hermsen R van Hoorn BA Kamm YJ Krabbe PF Corstens FH Punt CJ Oyen WJ Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer Ann Oncol 2008, 19(2):348-352. 17962202
18. Shin SS Jeong YY Min JJ Kim HR Chung TW Kang HK Preoperative staging of colorectal cancer: CT vs. integrated FDG PET/CT Abdom Imaging 2008, 33(3):270-277. 17610107
19. Weidner N Carroll PR Flax J Blumenfeld W Folkman J Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma Am J Pathol 1993, 143(2):401-409. 1887042 7688183
20. Chang YS di Tomaso E McDonald DM Jones R Jain RK Munn LL Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood Proc Natl Acad Sci USA 2000, 97(26):14608-14613. 18966 11121063
21. Chomczynski P Sacchi N Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 1987, 162(1):156-159. 2440339
22. Yeh CS Wang JY Wu CH Chong IW Chung FY Wang YH Yu YP Lin SR Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel Int J Oncol 2006, 28(2):411-420. 16391796
23. Wang JY Yeh CS Chen YF Wu CH Hsieh JS Huang TJ Huang SY Lin SR Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer Int J Mol Med 2006, 17(5):737-747. 16596255
24. Chen YF Shin SJ Lin SR Ets1 was significantly activated by ERK1/2 in mutant K-ras stably transfected human adrenocortical cells DNA Cell Biol 2005, 24(2):126-132. 15699632
25. Chen YF Wang JY Wu CH Chen FM Cheng TL Lin SR Detection of circulating cancer cells with K-ras oncogene using membrane array Cancer Lett 2005, 229(1):115-122. 16157223
26. Brenes GA Paskett ED Predictors of stage of adoption for colorectal cancer screening Prev Med 2000, 31(4):410-416. 11006067
27. Parkin DM Global cancer statistics in the year 2000 Lancet Oncol 2001, 2(9):533-543. 11905707
28. Ghafoor A Jemal A Cokkinides V Cardinez C Murray T Samuels A Thun MJ Cancer statistics for African Americans CA Cancer J Clin 2002, 52(6):326-341. 12469762
29. Pohl C Hombach A Kruis W Chronic inflammatory bowel disease and cancer Hepatogastroenterology 2000, 47(31):57-70. 10690586
30. Greenlee RT Murray T Bolden S Wingo PA Cancer statistics, 2000 CA Cancer J Clin 2000, 50(1):7-33. 10735013
31. Komuta K Koji T Izumi S Matsumoto T Kohara N Motojima K Kanematsu T Nakane PK Expression of epidermal growth factor receptor messenger RNA in human colorectal carcinomas assessed by non-radioactive in-situ hybridization Eur J Surg Oncol 1995, 21(3):269-275. 7781795
32. Kapitanovic S Radosevic S Kapitanovic M Andelinovic S Ferencic Z Tavassoli M Primorac D Sonicki Z Spaventi S Pavelic K et al The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer Gastroenterology 1997, 112(4):1103-1113. 9097992
33. Wenger RH Mammalian oxygen sensing, signalling and gene regulation J Exp Biol 2000, 203(Pt 8):1253-1263. 10729275
34. Iyer NV Kotch LE Agani F Leung SW Laughner E Wenger RH Gassmann M Gearhart JD Lawler AM Yu AY et al Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha Genes Dev 1998, 12(2):149-162. 316445 9436976
35. Chen CC Hou MF Wang JY Chang TW Lai DY Chen YF Hung SY Lin SR Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/ neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis Cancer Lett 2006, 240(2):279-288. 16289546
36. Dang CV Semenza GL Oncogenic alterations of metabolism Trends Biochem Sci 1999, 24(2):68-72. 10098401
37. Pedersen PL Tumor mitochondria and the bioenergetics of cancer cells Prog Exp Tumor Res 1978, 22:190-274. 149996
38. Weinhouse S Glycolysis, respiration, and anomalous gene expression in experimental hepatomas: G.H.A. Clowes memorial lecture Cancer Res 1972, 32(10):2007-2016. 4343003
39. Burk D Woods M Hunter J On the significance of glucolysis for cancer growth, with special reference to Morris rat hepatomas J Natl Cancer Inst 1967, 38(6):839-863. 4381692
40. Keller K Strube M Mueckler M Functional expression of the human HepG2 and rat adipocyte glucose transporters in Xenopus oocytes. Comparison of kinetic parameters J Biol Chem 1989, 264(32):18884-18889. 2553725
41. Burant CF Takeda J Brot-Laroche E Bell GI Davidson NO Fructose transporter in human spermatozoa and small intestine is GLUT5 J Biol Chem 1992, 267(21):14523-14526. 1634504
42. Birnbaum MJ Haspel HC Rosen OM Cloning and characterization of a cDNA encoding the rat brain glucose-transporter protein Proc Natl Acad Sci USA 1986, 83(16):5784-5788. 386379 3016720
43. Fukumoto H Seino S Imura H Seino Y Bell GI Characterization and expression of human HepG2/erythrocyte glucose-transporter gene Diabetes 1988, 37(5):657-661. 2834252
44. Warburg O [Origin of cancer cells] Oncologia 1956, 9(2):75-83. 13335077
45. Noguchi Y Saito A Miyagi Y Yamanaka S Marat D Doi C Yoshikawa T Tsuburaya A Ito T Satoh S Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth Cancer Lett 2000, 154(2):175-182. 10806305
46. Shao SL Cai Y Wang QH Yan LJ Zhao XY Wang LX [Expression of GLUT-1, p63 and DNA-Pkcs in serous ovarian tumors and their significance] Zhonghua Zhong Liu Za Zhi 2007, 29(9):697-700. 18246802
47. Endo M Tateishi U Seki K Yamaguchi U Nakatani F Kawai A Chuman H Beppu Y Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas Jpn J Clin Oncol 2007, 37(12):955-960. 18211986
48. Ciampi R Vivaldi A Romei C Del Guerra A Salvadori P Cosci B Pinchera A Elisei R Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors Mol Cell Endocrinol 2008, 291(1-2):57-62. 18571834
49. Ozbudak IH Karaveli S Simsek T Erdogan G Pestereli E Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas Gynecol Oncol 2008, 108(3):603-608. 18191183
50. Mayer A Hockel M Vaupel P Endogenous hypoxia markers: Case not proven! Adv Exp Med Biol 2008, 614:127-136. 18290322
51. Nguyen XC So Y Chung JH Lee WW Park SY Kim SE High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-D-glucose uptake Eur J Cancer 2008, 44(5):692-698. 18314327